BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28754634)

  • 21. Androgen receptor regulates SRC expression through microRNA-203.
    Siu MK; Chen WY; Tsai HY; Yeh HL; Yin JJ; Liu SY; Liu YN
    Oncotarget; 2016 May; 7(18):25726-41. PubMed ID: 27028864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.
    Ding M; Lin B; Li T; Liu Y; Li Y; Zhou X; Miao M; Gu J; Pan H; Yang F; Li T; Liu XY; Li R
    Oncotarget; 2015 Apr; 6(10):7686-700. PubMed ID: 25797256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.
    Ribas J; Lupold SE
    Cell Cycle; 2010 Mar; 9(5):923-9. PubMed ID: 20160498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines.
    Ramamurthy VP; Ramalingam S; Gediya L; Kwegyir-Afful AK; Njar VC
    Oncotarget; 2015 Feb; 6(5):3195-210. PubMed ID: 25605250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus-induced miR-142-5p elicits proviral milieu by targeting non-canonical transforming growth factor beta signalling and apoptosis in cells.
    Chanda S; Nandi S; Chawla-Sarkar M
    Cell Microbiol; 2016 May; 18(5):733-47. PubMed ID: 26572508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
    Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
    BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.
    Lichner Z; Ding Q; Samaan S; Saleh C; Nasser A; Al-Haddad S; Samuel JN; Fleshner NE; Stephan C; Jung K; Yousef GM
    J Pathol; 2015 Oct; 237(2):226-37. PubMed ID: 26011734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.
    Atala A
    J Urol; 2015 Apr; 193(4):1442. PubMed ID: 25890570
    [No Abstract]   [Full Text] [Related]  

  • 30. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-181a-5p enhances cell proliferation in medullary thymic epithelial cells via regulating TGF-β signaling.
    Guo D; Ye Y; Qi J; Zhang L; Xu L; Tan X; Yu X; Liu Q; Liu J; Zhang Y; Ma Y; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):840-9. PubMed ID: 27411504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
    Pasqualini L; Bu H; Puhr M; Narisu N; Rainer J; Schlick B; Schäfer G; Angelova M; Trajanoski Z; Börno ST; Schweiger MR; Fuchsberger C; Klocker H
    Mol Endocrinol; 2015 Jul; 29(7):1037-54. PubMed ID: 26052614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor suppresses prostate cancer cell invasion via altering the miR-4496/β-catenin signals.
    Wang RF; Wang ZF; Cheng Q; Wang GR; Bai ZM
    Biochem Biophys Res Commun; 2018 Sep; 504(1):82-88. PubMed ID: 30177389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.
    Wei F; Wang Q; Su Q; Huang H; Luan J; Xu X; Wang J
    Cell Mol Neurobiol; 2016 Nov; 36(8):1389-1397. PubMed ID: 26858153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG
    Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
    Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
    PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.